Severe Acute Respiratory Syndrome

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in February 2003. Over the next few months, the illness spread to more than two dozen countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained.
Severe Acute Respiratory Syndrome

SARS or Severe Acute Respiratory Syndrome is a viral respiratory illness caused by a coronavirus - the SARS associated coronavirus (SARS-CoV) - which can be life-threatening.

Read More

Overview

Latest Severe Acute Respiratory Syndrome News and Research

A backbone free energy study of SARS-CoV-2 variants of concern

A backbone free energy study of SARS-CoV-2 variants of concern

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

Early tracheostomy could reduce recovery time in critical COVID-19, say researchers

Early tracheostomy could reduce recovery time in critical COVID-19, say researchers

One in seven people in England show SARS-CoV-2 antibodies, finds study

One in seven people in England show SARS-CoV-2 antibodies, finds study

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

Researchers to conduct large meta-analysis of fetomaternal complications in COVID-19

Researchers to conduct large meta-analysis of fetomaternal complications in COVID-19

Researchers assess SARS-CoV-2 surface contamination risks in hospital setting

Researchers assess SARS-CoV-2 surface contamination risks in hospital setting

FDA issues EUA for third COVID-19 vaccine

FDA issues EUA for third COVID-19 vaccine

New evidence of SARS-CoV-2 spreading on planes

New evidence of SARS-CoV-2 spreading on planes

New SARS-CoV-2 B.1.526 variant emerges in New York

New SARS-CoV-2 B.1.526 variant emerges in New York

Free-ranging minks exhibit high titers of SARS-CoV-2 antibodies in Utah

Free-ranging minks exhibit high titers of SARS-CoV-2 antibodies in Utah

Time to implement measures preventing future viral zoonoses

Time to implement measures preventing future viral zoonoses

SARS-CoV-2 modulates host cell central carbon metabolism for reproduction

SARS-CoV-2 modulates host cell central carbon metabolism for reproduction

New method to enhance images of the SARS-CoV-2 virus

New method to enhance images of the SARS-CoV-2 virus

New study assesses COVID-19 risk among UK healthcare workers

New study assesses COVID-19 risk among UK healthcare workers

NLRP3 inflammasome inhibitors may help treat early COVID-19, says study

NLRP3 inflammasome inhibitors may help treat early COVID-19, says study

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants